Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
Public ClinicalTrials.gov record NCT06291376. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Immunoglobulin A Nephropathy (IgAN)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study to evaluate efficacy of ravulizumab compared with placebo on proteinuria reduction and change in eGFR in adult participants with IgAN who are at risk of disease progression.
Study identification
- NCT ID
- NCT06291376
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 579 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 28, 2024
- Primary completion
- Jan 4, 2026
- Completion
- Jul 18, 2030
- Last update posted
- Jun 21, 2026
2024 – 2030
United States locations
- U.S. sites
- 39
- U.S. states
- 16
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Alabaster | Alabama | 35007 | — |
| Research Site | Phoenix | Arizona | 85054 | — |
| Research Site | Los Angeles | California | 90022 | — |
| Research Site | Los Angeles | California | 90027 | — |
| Research Site | Los Angeles | California | 90095 | — |
| Research Site | Orange | California | 92868 | — |
| Research Site | San Bernardino | California | 92408 | — |
| Research Site | San Diego | California | 92120 | — |
| Research Site | San Francisco | California | 94143 | — |
| Research Site | Stanford | California | 94305 | — |
| Research Site | Torrance | California | 90502 | — |
| Research Site | Valencia | California | 91355 | — |
| Research Site | Bay Pines | Florida | 33744 | — |
| Research Site | Miami | Florida | 33136 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | Acworth | Georgia | 30101 | — |
| Research Site | Atlanta | Georgia | 30322 | — |
| Research Site | Lawrenceville | Georgia | 30046 | — |
| Research Site | New Orleans | Louisiana | 70121 | — |
| Research Site | Boston | Massachusetts | 02111 | — |
| Research Site | Boston | Massachusetts | 02114 | — |
| Research Site | Boston | Massachusetts | 02115 | — |
| Research Site | Worcester | Massachusetts | 01655 | — |
| Research Site | Minneapolis | Minnesota | 55435 | — |
| Research Site | Minneapolis | Minnesota | 55455 | — |
| Research Site | Kansas City | Missouri | 64111 | — |
| Research Site | North Las Vegas | Nevada | 89086 | — |
| Research Site | Albany | New York | 12208 | — |
| Research Site | New York | New York | 10016 | — |
| Research Site | The Bronx | New York | 10468 | — |
| Research Site | Columbus | Ohio | 43210 | — |
| Research Site | Knoxville | Tennessee | 37920 | — |
| Research Site | Arlington | Texas | 76002 | — |
| Research Site | Houston | Texas | 77030 | — |
| Research Site | Houston | Texas | 77054 | — |
| Research Site | San Antonio | Texas | 78229 | — |
| Research Site | Shenandoah | Texas | 77384 | — |
| Research Site | Charlottesville | Virginia | 22908 | — |
| Research Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 207 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06291376, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 21, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06291376 live on ClinicalTrials.gov.